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Male factor infertility accounts for 40–50% of all infertility cases. Deletions of one or more AZF region parts in chromosome Y 
are one of the most common genetic causes of male infertility. Usually full or partial AZF deletions, including genes involved in 
spermatogenesis, are associated with spermatogenic failure. Here we report a case of a Caucasian man with partial AZFa region 
deletion from a couple with secondary infertility. Partial AZFa deletion, involving part of USP9Y gene appears to be benign, as we 
proved transmission from father to son. According to our results, it is recommended to revise guidelines on markers selected for 
testing of AZFa region deletion, to be more selective against DDX3Y gene and exclude probably benign microdeletions involving 
only USP9Y gene.
1. Background
Male factor infertility accounts for 40–50% of all infertility cases. 
Deletions of one or more AZF region parts in chromosome Y 
are one of the most common genetic causes of male infertility. 
Microdeletions of AZF regions in Y chromosome occur as de 
novo event in 2–10% nonobstructive azoospermia or olig-
ospermia cases [1–3]. Usually full or partial AZF deletions, 
including genes involved in spermatogenesis, are associated with 
spermatogenic failure. Entire AZFa deletions are induced by 
recombination between HERV15 class proviruses with ~800 kb 
distance [4–6].  is sort of Y chromosome’s microdeletions 
might be the cause of Sertoli cell only (SCO) syndrome—a total 
lack of spermatogenesis [7].  ere are several events reported 
about the inheritance of di¤erent AZF regions’ deletions from 
fathers to their sons [8–10]. Real time polymerase chain 
reaction, using STS markers as stated by the European Academy 
of Andrology (EAA) and the European Molecular Genetics 
Quality Network (EMQN), is a convenient screening method 
to detect these changes [11]. Unfortunately, this testing approach 
might give false positive results due to single nucleotide poly-
morphisms (SNPs) in primer annealing site (peculiar for Asian 
populations) [12]. Also, conventional screening for AZFa and 
AZFb deletions includes PCR of two STS markers (sY84 and 
sY86 for AZFa region, sY127 and sY134 for AZFb region), 
which do not ©ank genes, important in sperm development, 
from both sides.  erefore, false positive outcome of AZFa or 
AZFb deletion might appear, as the test detects only the absence 
of these STS markers, not the absence of genes.
Here we report a case of a Caucasian man with partial 
AZFa region deletion from a couple with secondary infertility. 
Aim of the study was to evaluate the size and involved genes 
of partial AZFa region deletion detected in a man with normal 
semen analysis.
2. Case Presentation
Patient at the time of appointment in fertility clinic was 
31 years old, healthy individual. His partner was 27 years old 
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woman with one missed pregnancy at week 6 in anamnesis. 
All tested hormonal and biochemical markers—prolactin, 
vitamin D, testosterone, T4 and TSH—were in normal range. 
Semen analysis did not show significant changes in volume, 
concentration and sperm motility. e count of the round 
cells—1mil/ml, did not exceed reference levels of normal cri-
teria. Percentage of morphologically normal spermatozoa was 
slightly deteriorated—4% cells with normal morphology, 
amorphous sperm heads, altered acrosomal distribution and 
enlarged necks. Sperm DNA fragmentation test did not show 
increased sperm DNA damage, fragmented DNA occurred in 
13% of cells by HaloKit test (<16% DNA fragmentation is 
associated with normal fertility level). e patient was referred 
for AZF microdeletion testing aer karyotype analysis, which 
revealed normal 46, XY karyotype, but showed slightly 
decreased levels of constitutive heterochromatin in the long 
arm of chromosome Y.
Genomic DNA was extracted, using Magpurix Blood 
DNA Extraction Kit 200, according to the manufacturer’s 
protocol. Analysis of AZF region deletions was performed 
using AZF System Y-chromosome (Sacace) reagents’ kit. is 
Real Time PCR test is based on the amplification of two, 
specific, nonpolymorphic STS locuses in each region of Y 
chromosome—AZFa, AZFb and AZFc. e STS locuses used 
in this kit for detection of AZF regions deletions are: AZFa: 
sY84, sY86, AZFb: sY127, sY134, AZFc: sY254, sY255, as 
recommended in the guidelines of American and European 
Andrology societies (ref…). e sensitivity of this method 
is >95%.
Analyzing patient’s DNA, amplification of STS markers 
AZFa: sY86, AZFb: sY127, sY134, AZFc: sY254, sY255, were 
detected, so these regions are all present in patient’s genome. 
Amplification product of AZFa: sY84 was absent, and deletion 
of AZFa regions’ STS sY84 was confirmed by repeated analysis.
As full deletion of AZFa region is linked with severely 
impaired spermatogenesis, but patient had normal semen 
analysis with only slight deviations, more detailed analysis of 
AZFa region was performed.
To exclude SNP in region of primer binding sites of sY84, 
PCR with redesigned primers and subsequent capillary electro-
phoresis were performed. Primers were as described previously, 
PCR conditions are available under request (Table 1, [12]). 
Normal control DNA from male without AZFa deletion, had 
amplification product and sequence of AZFa region was 
obtained, but patients’ DNA did not amplify PCR product and 
sequencing was not possible. erefore, it was concluded, that 
patient has deletion in AZFa region.
For determining the size of deletion, markers and PCR 
primers, specific for distinct locations in AZFa region, were 
found, using MSY Breakpoint Mapper (Table 1, [13]). is 
database of sequence-tagged sites (STSs) gives a possibility for 
more precise mapping of deletions in the male-specific region 
of the human Y chromosome.
PCR assays for all markers to determine the approximate 
size of deletion and involved genes (Table 1) were performed, 
using nuclease free water, 10x PCR buffer (20 mM MgCl2), 
10 mM dNTP, betaine, 10 nM primer mixes and 1Uµl Taq 
 polymerase. PCR conditions are available under request.
Analysis of patients’ father DNA was performed to inves-
tigate, whether the AZFa deletion is passed from father to son.
Deletion of both Y chromosomes’ STSs sY84 and sY1323 
was detected in patients’ (Figure 1, lanes 1–7) and his father 
DNA samples (lanes 9–16), when compared to positive control 
(healthy male DNA) (lanes 18–24), confirming the inheritance 
of this region’s deletion. None of markers were visualized from 
DNA of infertile male with full AZFa region deletion (lanes 
26–32).  
e deletion spans sY84 and sY1323 markers, removing 
part of one of the AZFa region gene USP9Y and leaving second 
AZFa gene DDX3Y intact (Figure 2). AZFa partial microde-
letion was detected, removing part of AZFa non-coding region 
and 5′ part of USP9Y gene, as testing USP9Y deletion with STS 
markers in both ends of the gene, sY1323 and USP9Y-44, 
showed, that 3′ marker USP9Y-44 was present. Moreover, STS 
sY84—a marker upstream the USP9Y, and sY1323—a marker 
in 5′ start of the gene, were absent, and this result confirms 
Table 1:  Markers, used for the detection of AZFa region deletion size (#Wu et al. [12], ∗MSY Breakpoint Mapper [13]), F—forward, 
R—reverse.

























DDX3Y-16∗ (intragenic) Y:12917260–12917716 F—TGGGACATTAATGGGATGGT 457 bp
R—GTTGCCACCCACCTGTAATC
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partial AZFa and USP9Y deletion. Exact breakpoints were not 
mapped, and sequencing of full AZFa region was not per-
formed due to technical issues. Also, the deletion was already 
proven with marker testing, and it was not necessary to do full 
AZFa region investigation. As results of marker testing was 
the same for father of patient, we proved germline transmis-
sion of deletion from father to son and excluded de novo event.
3. Discussion
In this case report, germline transmitted Y chromosomes’ 
AZFa partial microdeletion was detected, removing part 
of AZFa noncoding region and 5′ part of USP9Y gene. Partial 
AZFa deletions not always a¤ects spermatogenesis, and sperm 
production in these cases might be essentially impaired only, 
if aberrations of one AZFa gene DDX3Y, are involved. In this 
case, the deletion did not a¤ect sperm cell production, as 
almost all the sperm quality parameters were in normal range. 
 ere are evidences, that USP9Y has a role in spermatogenesis, 
changes in it is related to mild oligozoospermia phenotypes 
and are compatible with fertility [14, 15]. Liu et al. in a com-
prehensive research found partial AZFa microdeletion, includ-
ing loss of marker Y86, from nt 14469266 to 14607672 in 
sub-fertile father and son [16]. Luddi et al. has demonstrated 
that one of the two AZFa region genes, USP9Y, deletion is not 
a major cause of oligoastenozoospermia or azoospermia, and 
carriers of this microdeletion have normal sperm parameters 
[17]. Also, missense variants of the USP9Y do not have con-
stitutive impact on male infertility. Banks et al. performed in 
silico analysis of USP9Y variants and found out that all males 
with predicted protein damaging variants were able to have 
siblings without assisted reproductive therapies, therefore 
establishing the fact, that USP9Y has a minor role in game-
togenesis [18].
 e role of USP9Y remains questionable, as in some ani-
mals, for example, chimpanzees, this gene expression has 
stopped, and still their spermatogenesis progresses normally 
[19]. USP9Y has a homolog USP9X with 97% approximate 
identity and cognate expression in early stages of the devel-
opment of gametes [20]. Krausz et al. had presented two cases, 
that AZFa deletions, including USP9Y, might be inherited 
Figure 1: PCR products of all tested AZFa region markers. 1000 bp ladder was used as the size control (lanes 8, 16, 24, 32). Lanes 1–7: Patient’s 
DNA sample. Lanes 9–15: DNA sample of the father of patient. Lanes 17–23: Positive control (healthy male without AZF deletions). Lanes 
25–31: Negative control (male with full AZFa deletion). Lanes 33–39: No template control. For each sample, PCR products representing the 
tested markers are shown in following order: sY85: lanes no. 1, 9, 17, 26, 33; sy84: lanes no. 2, 10, 18, 26, 34; sY1323: lanes no. 3, 11, 19, 27, 35; 
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Figure 2: Schematic drawing of the tested STS markers. Partial deletion of AZFa is marked with red box.
Case Reports in Genetics4
“Double-blind Y chromosome microdeletion analysis in men 
with known sperm parameters and reproductive hormone 
profiles: microdeletions are specific for spermatogenic failure,” 
Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 6, 
pp. 2638–2642, 2001.
 [2]  M. Simoni, F. Tüttelmann, J. Gromoll, and E. Nieschlag, 
“Clinical consequences of microdeletions of the Y chromosome: 
e extended Münster experience,” Reproductive BioMedicine 
Online, vol. 16, no. 2, pp. 289–303, 2008.
 [3]  D. Lo Giacco, C. Chianese, J. Sánchez- Curbelo et al., “Clinical 
relevance of Y-linked CNV screening in male infertility: new 
insights based on the 8-year experience of a diagnostic genetic 
laboratory,” European Journal of Human Genetics, vol. 22, no.  6, 
pp. 754–761, 2014.
 [4]  X.-W. Yu, Z.-T. Wei, Y.-T. Jiang, and S.-L. Zhang, “Y chromosome 
azoospermia factor region microdeletions and transmission 
characteristics in azoospermic and severe oligozoospermic 
patients,” International Journal of Clinical and Experimental 
Medicine, vol. 8, no. 9, pp. 14634–14646, 2015.
 [5]  P. Blanco, M. Shlumukova, C. A. Sargent, M. A. Jobling, N. Affara, 
and M. E. Hurles, “Divergent outcomes of intrachromosomal 
recombination on the human Y chromosome: male infertility 
and recurrent polymorphism,” Journal of Medical Genetics, 
vol.  37, no. 10, pp. 752–758, 2000.
 [6]  C. Kamp, P. Hirschmann, H. Voss, K. Huellen, and 
P. H. Vogt, “Two long homologous retroviral sequence blocks 
in proximal Yq11 cause AZFa microdeletions as a result of 
intrachromosomal recombination events,” Human Molecular 
Genetics, vol. 9, no.  17, pp. 2563–2572, 2000.
 [7]  K. Ramphul, H. Zulfiqar, and S. G. Mejias, “Sertoli-Cell-Only 
Syndrome,” StatPearls Publishing, 2019.
 [8]  H. Samli, M. Murat Samli, and M. Solak, “Natural transmission 
of AZFb Y-chromosomal microdeletion from father to his three 
sons,” Archives of Andrology, vol. 52, no. 6, pp. 423–426, 2006.
 [9]  A. E. Calogero, M. R. Garofalo, N. Barone et al., “Spontaneous 
transmission from a father to his son of a Y chromosome 
microdeletion involving the deleted in azoospermia (DAZ) 
gene,” Journal of Endocrinological Investigation, vol. 25, no. 7, 
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6563, 2018.
[11]  C. Krausz, L. Hoefsloot, M. Simoni, and F. Tüttelmann, 
“European academy of andrology, and european molecular 
genetics quality network, EAA/EMQN best practice guidelines 
for molecular diagnosis of Y-chromosomal microdeletions: 
state-of-the-art 2013,” Andrology, vol. 2, no. 1, pp. 5–19, 2014.
[12]  Q. Wu, G.–W. Chen, T.-F. Yan et al., “Prevalent false positives of 
azoospermia factor a (AZFa) microdeletions caused by single-
nucleotide polymorphism rs72609647 in the sY84 screening 
of male infertility,” Asian Journal of Andrology, vol. 13, no. 6, 
pp. 877–880, 2011.
[13]  J. Lange, H. Skaletsky, G. W. Bell, and D. C. Page, “MSY 
breakpoint mapper, a database of sequence-tagged sites useful 
in defining naturally occurring deletions in the human Y 
chromosome,” Nucleic Acids Research, vol. 36, no. 1, pp. D809–
D814, 2008.
[14]  S. E. Kleiman, R. Almog, L. Yogev et al., “Screening for partial 
AZFa microdeletions in the Y chromosome of infertile men: 
from fertile men to their offsprings. e fertility of these 
patients was impaired, and moderate oligoasthenoteratozoo-
spermia was observed in both cases, so probably this gene has 
a fine-tuning role in humans [21]. USP9Y might play a role 
in the post-meiotic stage of human sperm cell growth. In a 
case of one patient with spermatid arrest, a “de novo” deletion 
of 4 base pairs, encompassing splice donor site in exon 8, was 
found [22].
Similarly, to only USP9Y aberrations, phenotypes with full 
AZFa deletions, incorporating DDX3Y, show only changes in 
testicular development, without somatic phenotype alterations 
[23]. In male germ cells DDX3Y, which is usually omnipresent, 
undergoes strict control of translation in testis, and this specific 
transcript is mainly related to differentiation of spermatogonia 
and spermatocytes—premeiotic germ cells. According to this, 
DDX3Y should be regarded as the main AZFa region gene 
participating in sperm cell development [24].
e marginal role of USP9Y in sperm production may be 
explained by the replacing mechanisms of this gene homologs 
on X chromosome or autosomes, or other compensatory pro-
cesses [14]. In contrast to USP9Y, DDX3Y function cannot be 
dispensable by its homologue, DDX3X. Although DDX3X 
expression occurs globally in mice testis, they might be differ-
entially regulated [25].
4. Conclusion
Our results confirm the fact, that partial deletion of AZFa 
region and USP9Y does not affect fertility, as we have proved 
inheritance of the deletion from father to son, in father there 
are no documented fertility problems. We conclude that par-
tial deletions of AZFa region should be studied in details, to 
exclude or confirm involvement in impaired spermatogenesis, 
as only full deletion of AZFa region could be marker for infer-
tility. It is highly advisable to choose markers of AZFa region, 
which can confirm deletion of genes related to spermatogen-
esis. According to our results, it is recommended to revise 
guidelines on markers selected for testing of AZFa region 
deletion, to be more selective against DDX3Y gene and 
exclude probably benign microdeletions involving only 
USP9Y gene.
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